Wall Street Experts
ver. ZuMIgo(08/25)
IDEAYA Biosciences, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 4
EBIT TTM (mln): -227
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
20 |
28 |
51 |
23 |
7 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
43.0% |
82.3% |
-54.1% |
-70.1% |
Marża brutto |
0.0% |
0.0% |
-inf% |
-103.2% |
93.8% |
95.9% |
82.9% |
100.0% |
EBIT (mln) |
-14 |
-36 |
-44 |
-35 |
-50 |
-63 |
-134 |
-327 |
EBIT Δ r/r |
0.0% |
152.2% |
21.6% |
-20.2% |
42.2% |
24.3% |
115.1% |
143.2% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-180.9% |
-179.9% |
-122.7% |
-574.9% |
-4671.1% |
Koszty finansowe (mln) |
0 |
0 |
0 |
1 |
0 |
4 |
0 |
0 |
EBITDA (mln) |
-14 |
-36 |
-44 |
-35 |
-50 |
-60 |
-130 |
-327 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-180.9% |
-179.9% |
-122.7% |
-557.7% |
-4671.1% |
Podatek (mln) |
-0 |
2 |
-4 |
-2 |
-2 |
-4 |
0 |
0 |
Zysk Netto (mln) |
-12 |
-34 |
-38 |
-32 |
-48 |
-55 |
-113 |
-274 |
Zysk netto Δ r/r |
0.0% |
189.5% |
11.9% |
-16.1% |
47.3% |
15.3% |
106.1% |
143.0% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-165.1% |
-170.1% |
-107.6% |
-483.0% |
-3921.1% |
EPS |
-0.83 |
-2.41 |
-3.08 |
-1.31 |
-1.35 |
-1.32 |
-1.96 |
-3.36 |
EPS (rozwodnione) |
-0.83 |
-2.41 |
-3.08 |
-1.31 |
-1.35 |
-1.32 |
-1.96 |
-3.36 |
Ilośc akcji (mln) |
14 |
14 |
12 |
25 |
35 |
41 |
58 |
82 |
Ważona ilośc akcji (mln) |
14 |
14 |
12 |
25 |
35 |
41 |
58 |
82 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |